marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-08-2023
InVivo Therapeutics Holdings Corp. Income Statement 2011-2024 | NVIV
Annual Income Statement InVivo Therapeutics Holdings Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.15 M | 12.9 M | 5.7 M | 2.41 M | 8.38 M | 18.1 M | 146 M | 117 M | 173 M | 170 M | 132 M | 107 M |
Shares |
1.54 M | 1.32 M | 4.88 M | 335 K | 166 K | 43.9 K | 41.4 K | 35.3 K | 29.4 K | 24.7 K | 21.1 K | 17.3 K |
Historical Prices |
2.05 | 9.75 | 29.2 | 180 | 1.28 K | 9.94 K | 89.1 K | 83.1 K | 147 K | 165 K | 154 K | 169 K |
Net Income |
-10.5 M | -9.9 M | -9.07 M | -11.8 M | -23.4 M | -26.7 M | -23.4 M | -33.3 M | -18.3 M | -38.8 M | 4.66 M | -34.7 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-10.6 M | -9.9 M | -9.1 M | -11.5 M | -12.8 M | -24.6 M | -24.1 M | -22.4 M | -17.8 M | -19 M | -12.8 M | -8.66 M |
Interest Expense |
- | - | - | - | 1.3 M | 74 K | 155 K | 172 K | 136 K | 130 K | 71.7 K | 12.7 K |
EBITDA |
-10.6 M | -9.86 M | -8.77 M | -11.2 M | -12.7 M | -24.2 M | -23.5 M | -21.7 M | -17.1 M | -18.3 M | -12.4 M | -8.51 M |
Operating Expenses |
10.6 M | 9.9 M | 9.1 M | 11.5 M | 12.8 M | 24.6 M | 24.1 M | 22.4 M | 17.8 M | 19 M | 12.8 M | 8.66 M |
General and Administrative Expenses |
5.42 M | 5.52 M | 5.16 M | 5.9 M | 7.84 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement InVivo Therapeutics Holdings Corp.
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
3.11 M | 3.11 M | 2.74 M | 2.43 M | 1.39 M | 1.38 M | 1.37 M | 1.37 M | 1.37 M | 1.37 M | 1.18 M | 23.6 M | 4.88 M | 4.45 M | 976 K | 551 K | 310 K | 310 K | 310 K | 310 K | 7.56 M | 1.73 M | 1.43 M | 1.37 M | 1.34 M | 1.29 M | 1.28 M | 32 M | 32 M | 31.9 M | 28.2 M | 27.6 M | 27 M | 26.5 M | 24.9 M | 23.5 M | 23.4 M | 21.8 M | 18.5 M | 78.8 M | 78.6 M | 72.4 M | 66 M | 65.9 M | 65.1 M | 64.1 M | 58 M | 53.8 M | 51.9 M | 51.7 M | 51.7 M |
Net Income |
-2.7 M | -1.94 M | -2.33 M | - | -2.76 M | -2.72 M | -2.66 M | - | -2.45 M | -2.31 M | -2.22 M | - | -2.28 M | -2.19 M | -2.41 M | - | -2.68 M | -3.14 M | -2.64 M | - | -3.18 M | -12.9 M | -4.78 M | - | -9.35 M | -6.34 M | -6.39 M | - | -6.2 M | -5.18 M | -6.62 M | - | -2.31 M | -10.4 M | -15.8 M | - | -1.21 M | -3.65 M | -5.1 M | - | -5.44 M | -14.3 M | -13.3 M | - | 8.03 M | 2.2 M | 3.15 M | - | 3.07 M | -1.37 M | -1.28 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.83 M | -2.08 M | -2.49 M | - | -2.8 M | -2.73 M | -2.66 M | - | -2.45 M | -2.31 M | -2.22 M | - | -2.28 M | -2.2 M | -2.43 M | - | -2.73 M | -3.25 M | -2.78 M | - | -2.11 M | -2.81 M | -4.83 M | - | -6.32 M | -6.93 M | -6.67 M | - | -5.88 M | -5.79 M | -5.57 M | - | -5.87 M | -5.76 M | -5.51 M | - | -4.18 M | -4.74 M | -5.07 M | - | -5.41 M | -5.07 M | -2.85 M | - | -2.84 M | -2.76 M | -2.46 M | - | -2.21 M | -2.53 M | -1.4 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2 K | 1 K | 1 K | - | 834 K | 26 K | 42 K | - | 18 K | 20 K | 20 K | - | 32 K | 29 K | 63 K | - | 32 K | 32 K | 34 K | - | 35 K | 35 K | 33 K | - | 34 K | 33 K | 29 K | - | 12.5 K | 10.7 K | 5.01 K | - | 7.15 K | 8.68 K | 1.51 K |
EBITDA |
-2.82 M | -2.08 M | -2.47 M | - | -2.79 M | -2.72 M | -2.65 M | - | -2.42 M | -2.28 M | -2.21 M | - | -2.25 M | -2.17 M | -2.42 M | - | -2.69 M | -3.22 M | -2.76 M | - | -2.04 M | -2.75 M | -4.79 M | - | -5.93 M | -6.66 M | -6.53 M | - | -5.46 M | -5.5 M | -5.42 M | - | -5.34 M | -5.41 M | -5.33 M | - | -3.62 M | -4.36 M | -4.88 M | - | -4.86 M | -4.72 M | -2.68 M | - | -2.62 M | -2.66 M | -2.42 M | - | -2.11 M | -2.46 M | -1.37 M |
Operating Expenses |
2.83 M | 2.08 M | 2.49 M | - | 2.8 M | 2.73 M | 2.66 M | - | 2.45 M | 2.31 M | 2.22 M | - | 2.28 M | 2.2 M | 2.43 M | - | 2.73 M | 3.25 M | 2.78 M | - | 2.11 M | 2.81 M | 4.83 M | - | 6.32 M | 6.93 M | 6.67 M | - | 5.88 M | 5.79 M | 5.57 M | - | 5.87 M | 5.76 M | 5.51 M | - | 4.18 M | 4.74 M | 5.07 M | - | 5.41 M | 5.07 M | 2.85 M | - | 2.84 M | 2.76 M | 2.46 M | - | 2.21 M | 2.53 M | 1.4 M |
General and Administrative Expenses |
2.12 M | 1.37 M | 1.11 M | - | 1.63 M | 1.38 M | 1.23 M | - | 1.34 M | 1.38 M | 1.21 M | - | 1.24 M | 1.26 M | 1.38 M | - | 1.27 M | 1.53 M | 1.67 M | - | 1.18 M | 1.79 M | 3.43 M | - | 3.39 M | 3.72 M | 3.28 M | - | 2.58 M | 2.99 M | 3 M | - | 3.44 M | 3.21 M | 3.21 M | - | 1.8 M | 1.69 M | 1.83 M | - | 2.39 M | 2.48 M | 1.64 M | - | 1.47 M | 1.45 M | 1.52 M | - | 1.2 M | 1.14 M | 764 K |
All numbers in USD currency